期刊
CLINICAL TRANSPLANTATION
卷 36, 期 1, 页码 -出版社
WILEY
DOI: 10.1111/ctr.14514
关键词
cyclophosphamide; fludarabine; haploidentical transplantation; severe aplastic anemia; severe cardiotoxicity
资金
- National Key Research and Development Program of China [2017YFA0104500]
- National Natural Science Foundation of China [81621001]
- National Science and Technology Major Project [2017ZX09304021]
This study evaluated the feasibility and efficacy of a modified conditioning regimen in haploidentical HSCT for severe-cardiotoxic-risk SAA patients and found that the BuCy(low)Flu conditioning significantly decreased the incidence of severe cardiotoxicity while achieving favorable engraftment and survival rates. The results suggest that BuCy(low)Flu conditioning can be a feasible alternative for haplo-HSCT recipients at risk of severe cardiotoxicity.
Severe cardiotoxicity is a fatal complication during high-dose cyclophosphamide (Cy)-based conditioning in hematopoietic stem cell transplant (HSCT) for severe aplastic anemia (SAA). This study aimed to evaluate the feasibility and efficacy of a modified conditioning regimen in haploidentical HSCT (haplo-HSCT) for severe-cardiotoxic-risk SAA patients. This BuCy(low)Flu conditioning utilized busulfan (Bu, 3.2 mg/kg for 2 days), low-dose Cy (100 mg/kg), fludarabine (150 mg/m(2)), and rabbit antithymocyte globulin (rATG, 10 mg/kg). Compared to BuCy conditioning using high-dose Cy of 200 mg/kg, Bu of 3.2 mg/kg for 2 days, and rATG of 10 mg/kg, the incidence of severe cardiotoxicity of BuCy(low)Flu conditioning was significantly decreased (2.17% vs 12.80%, p = .032). The engraftment rates (100% for neutrophil and 84.44% for platelet) were favorable. The probabilities of 100-day transplant-related mortality were similar in the BuCy(low)Flu and the BuCy group (8.75% vs 10.53%, p = .671). Both 1-year overall survival (88.79% vs 84.66%, p = .357) and 1-year failure-free survival (84.78% vs 81.70%, p = .535) were comparable. The BuCy(low)Flu group had higher rates of cytomegalovirus and Epstein-Barr virus reactivation. In conclusion, the BuCy(low)Flu provided reduced severe cardiotoxicity, and achieved favorable engraftment and survival. Our results suggest BuCy(low)Flu conditioning can be a feasible alternative for haplo-HSCT recipients at risk of severe cardiotoxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据